Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-003621
Filing Date
2025-03-25
Accepted
2025-03-25 16:06:58
Documents
102
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K crvs-20241231x10k.htm   iXBRL 10-K 2822922
2 EX-4.7 crvs-20241231xex4d7.htm EX-4.7 35769
3 EX-19.1 crvs-20241231xex19d1.htm EX-19.1 122053
4 EX-21.1 crvs-20241231xex21d1.htm EX-21.1 6104
5 EX-23.1 crvs-20241231xex23d1.htm EX-23.1 1931
6 EX-31.1 crvs-20241231xex31d1.htm EX-31.1 13995
7 EX-31.2 crvs-20241231xex31d2.htm EX-31.2 14394
8 EX-32.1 crvs-20241231xex32d1.htm EX-32.1 7291
9 GRAPHIC crvs-20241231x10k007.jpg GRAPHIC 89851
  Complete submission text file 0001558370-25-003621.txt   11665366

Data Files

Seq Description Document Type Size
10 EX-101.SCH crvs-20241231.xsd EX-101.SCH 45268
11 EX-101.CAL crvs-20241231_cal.xml EX-101.CAL 66851
12 EX-101.DEF crvs-20241231_def.xml EX-101.DEF 276692
13 EX-101.LAB crvs-20241231_lab.xml EX-101.LAB 548881
14 EX-101.PRE crvs-20241231_pre.xml EX-101.PRE 475129
105 EXTRACTED XBRL INSTANCE DOCUMENT crvs-20241231x10k_htm.xml XML 2044187
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37719 | Film No.: 25768320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)